Ignite Creation Date:
2024-05-06 @ 1:38 PM
Last Modification Date:
2024-10-26 @ 1:17 PM
Study NCT ID:
NCT04074096
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-03
First Post:
2019-08-26
Brief Title:
Binimetinib Encorafenib Pembrolizumab - Stereotactic Radiosurgery in BRAFV600 Melanoma With Brain Metastasis
Sponsor:
UNICANCER
Organization:
UNICANCER
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-09-05
Start Date Type:
ACTUAL
Primary Completion Date:
2025-04-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-04-15
Completion Date Type:
ESTIMATED
First Submit Date:
2019-08-26
First Submit QC Date:
August 27 2019
Study First Post Date:
2019-08-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-31
Last Update Post Date:
2024-06-03
Last Update Post Date Type:
ACTUAL